Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by Staghorn69on Jun 18, 2017 12:57am
231 Views
Post# 26374948

RE:Cash is King

RE:Cash is King Well I'm born sure I feel you're counting the initial "China Deal" cash there, but we've allowed been sold a bill... I mean led to believe a REAL Pharma China Deal is coming for the 4050 suite..  now let's see if they can get more than that $18 Mil for what people tout as a better than $8 Billion drug......  I've been saying this for months, and Pierre has been publicly bragging about all the pharmas he's chatting with, but it's damn fine time for him to put this Chinese cash on the table.  His SRAM company deal needs to close.  Now. 
Bullboard Posts